Ocular pharmacokinetics of verapamil in rabbits

被引:0
|
作者
A. Ettl
U. Hofmann
Albert Daxer
Hermann Dietrich
Eduard Schmid
Michel Eichelbaum
机构
[1] Allgemeines Krankenhaus,
[2] P. O. Box 176,undefined
[3] A-3100 St. Pölten,undefined
[4] Austria,undefined
[5] Department of Ophthalmology,undefined
[6] University of Innsbruck,undefined
[7] Innsbruck,undefined
[8] Austria,undefined
[9] Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,undefined
[10] Stuttgart,undefined
[11] Germany,undefined
[12] Central Laboratory Animal Facilities,undefined
[13] University of Innsbruck,undefined
[14] Innsbruck,undefined
[15] Austria,undefined
关键词
Key words Verapamil; Pharmacokinetics; Eye; Cataract; Glaucoma;
D O I
暂无
中图分类号
学科分类号
摘要
Previously, it had been demonstrated that cataract in diabetic rats can be prevented by systemical administration of the calcium channel blocker verapamil. In addition to that, 0.125% verapamil eye drops were found to significantly reduce the intraocular pressure in ocular hypertensive human subjects. The purpose of this study was to investigate the ocular penetration and elimination of verapamil after topical administration of the drug in rabbits. Two drops of a 0.125% aqueous solution of RS-verapamil hydrochloride (corresponding to a total dose of 125 μg RS-verapamil hydrochloride) were administered into the conjunctival sac. Aqueous humor and blood samples were taken at different times after administration and analysed for drug concentration by combined gas chromatography-mass spectroscopy.
引用
收藏
页码:331 / 335
页数:4
相关论文
共 50 条
  • [21] Rufloxacin eyedrops: Effect of different formulations on ocular pharmacokinetics in rabbits
    Burgalassi, S
    Cappello, B
    Chetoni, P
    Iervolino, M
    Monti, D
    Saettone, MF
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2006, 16 (02) : 311 - 317
  • [22] Pharmacokinetics of Uridine Following Ocular, Oral and Intravenous Administration in Rabbits
    Kim, Eunyoung
    Kang, Wonku
    BIOMOLECULES & THERAPEUTICS, 2013, 21 (02) : 170 - 172
  • [23] Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits
    Sasaki, H
    Yamamura, K
    Mukai, K
    Nishida, K
    Nakamura, J
    Nakashima, M
    Ichikawa, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1999, 22 (11) : 1253 - 1255
  • [24] OCULAR PHARMACOKINETICS OF SAPERCONAZOLE IN RABBITS - A POTENTIAL AGENT AGAINST KERATOMYCOSES
    ODAY, DM
    HEAD, WS
    ROBINSON, RD
    WILLIAMS, TE
    WOLFF, R
    ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (04) : 550 - 554
  • [25] Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits
    Isobe, Tomoyuki
    Kasai, Taku
    Kawai, Hiroyuki
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (07) : 405 - 414
  • [26] Ocular Penetration and Pharmacokinetics of Topical Clarithromycin Eye Drops to Rabbits
    Zhang, Junjie
    Wang, Liya
    Zhou, Jing
    Zhang, Li
    Xia, Huiyun
    Zhou, Tianyang
    Zhang, Hongmin
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (01) : 42 - 48
  • [27] Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits
    Fayyaz, Anam
    Ranta, Veli-Pekka
    Toropainen, Elisa
    Vellonen, Kati-Sisko
    Ricci, Giuseppe D'Amico
    Reinisalo, Mika
    Heikkinen, Emma M.
    Gardner, Iain
    Urtti, Arto
    Jamei, Masoud
    del Amo, Eva M.
    MOLECULAR PHARMACEUTICS, 2020, 17 (02) : 588 - 594
  • [28] OCULAR PHARMACOKINETICS AND PHARMACODYNAMICS IN RABBITS OF IBOPAMINE, A NEW MYDRIATIC AGENT
    SOLDATI, L
    GIANESELLO, V
    GALBIATI, I
    GAZZANIGA, A
    VIRNO, M
    EXPERIMENTAL EYE RESEARCH, 1993, 56 (02) : 247 - 254
  • [29] The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits
    Schoenwald, RD
    Zhu, JY
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (05) : 481 - 495
  • [30] Comparative pharmacokinetics of verapamil in normal, pregnant and lactating rabbits after intravenous administration
    Solans, C
    Fraile, LJ
    Rueda, S
    Aramayona, JJ
    Garcia, MA
    Bregante, MA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R403 - R403